TG Therapeutics, Inc. (TGTX)
39.47
-0.05
(-0.13%)
USD |
NASDAQ |
May 18, 16:00
39.29
-0.18
(-0.46%)
After-Hours: 05:59
TG Therapeutics Research and Development Expense (Quarterly) : 48.40M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 13.81M |
| Precision BioSciences, Inc. | 12.83M |
| AnaptysBio, Inc. | 33.86M |
| Catalyst Pharmaceuticals, Inc. | 2.661M |
| Geron Corp. | 14.96M |